SBFM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sunshine Biopharma Inc (SBFM) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The technical indicators are bearish, financial performance shows declining revenue and EPS, and there are no significant positive catalysts or trading signals. Holding off on this stock is advisable until stronger growth trends or positive signals emerge.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 45.81, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.051, with resistance at 1.135 and support at 0.968.
Hedge funds are significantly increasing their buying activity, with a 11812.88% increase in the last quarter.
No recent news, bearish technical indicators, declining financial performance (revenue, net income, and EPS), and a predicted negative trend for the next day, week, and month.
In Q4 2025, revenue dropped by -10.61% YoY to $8,577,141, net income declined by -0.80% YoY to -$2,140,927, and EPS fell by -56.00% YoY to -0.44. However, gross margin improved by 8.27% YoY to 34.16%.
No analyst rating or price target changes were provided.
